Moberg Pharma AB (publ) (STO:MOB)
Sweden flag Sweden · Delayed Price · Currency is SEK
11.08
+0.14 (1.28%)
Aug 14, 2026, 5:29 PM CET

Moberg Pharma AB Financials Overview

Millions SEK. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
16.7613.549.81-0.21-
Revenue Growth
35.76%37.99%----
Gross Profit
10.447.686.32-0.21-
Operating Income
-20.72-28-324.89-27.91-20.52-19.73
Net Income
-21.62-27.24-255.11-21.09-15.717.49
Earnings Per Share
-0.47-0.58-6.74-1.33-2.071.70
EPS Growth
------44.56%

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
212.43230.95293.2960.56125.55102.66
Total Debt
1.722.554.144.746.113.93
Net Cash (Debt)
210.71228.4289.1555.82119.4598.72
Net Cash Growth
-16.18%-21.01%418.02%-53.27%20.99%730.24%
Net Cash Per Share
4.534.887.643.5215.7422.94

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-13.45-17.49-16.47-33.21-16.84-15.3
Capital Expenditures
------
Free Cash Flow
-13.45-17.49-16.47-33.21-16.84-15.3
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
62.31%56.73%64.37%-100.00%-
Operating Margin
-123.61%-206.80%-3311.46%--9911.59%-
Pretax Margin
-102.57%-177.41%-3266.48%--9426.09%-
Profit Margin
-128.96%-201.18%-2600.26%--7589.37%-
FCF Margin
-80.23%-129.18%-167.87%--8136.23%-

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-----31.57
Forward PE
-91.9091.9091.9091.9091.90
PS Ratio
31.0735.6648.40-1101.38-